SAFC Pharma Augments Assay Development Capabilities

News   Jan 30, 2009

 
SAFC Pharma Augments Assay Development Capabilities
 
 
 

RELATED ARTICLES

Quotient Sciences Acquires Pharmaterials, a UK-based Contract Development and Manufacturing Organization

News

Quotient Sciences, the drug development services organization, announces it has acquired Pharmaterials, a contract development and manufacturing organization (CDMO) based in Reading, U.K..

READ MORE

BOC Sciences Continues to Enlarge Its Publication Collection Using BOC Sciences Products

News

BOC Sciences continues to add more publication items that used BOC Sciences products in their researches to its already existing collection.

READ MORE

Attacking Telomeres Offers First Effective Glioblastoma Therapy

News

Blocking TRF1 – a telomere protector – interrupts tumour growth and increases survival in various mouse models of glioblastoma.

READ MORE

 

Comments | 0 ADD COMMENT

Like what you just read? You can find similar content on the communities below.

Drug Discovery

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE